Montana Prescription Drug Registry (MPDR) Information
Check The History. It Matters.
If you are having trouble with the MPDR search screen:
If the search screen does not respond when you enter search parameters, then please do the following:
- Configure your browser to run in compatibility mode.
- Clear your browser’s history.
- Close the browser completely – shut down all tabs and windows.
- Re-open your browser and access the MPDR at www.mdpr.mt.gov.
These steps should resolve the issue. Ask your technical team for assistance if you don’t know how to perform any of the above steps. You can also call the MPDR’s technical team at 406-449-3468, Option 0.UPCOMING EVENT – Missoula Forum for Children & Youth, April 16, 2014. Presented by an alliance of prevention coalitions, agencies and individuals, this summit includes two sessions discussing prescription drug abuse issues. Look for the MPDR’s display table at the event. For more information or to register to attend, go to http://missoulaforum.org.
Online Training Program All providers who are eligible for online access must first complete this training.
Register for Online Access to Patient Histories: NOTE: you must first complete the above training program
Register to Report Pharmacy Prescription Data to the MPDR
MPDR Illustrated Guide for Pharmacy Staff – instructions for monitoring data submissions, correcting errors, and much more.
Links to Application Forms:
The following individuals can apply for online access to the MPDR by submitting a form to the MPDR office:
People who are not eligible for online access to the MPDR can use these forms to request information:
Law Enforcement Access to the MDPR: Submit an investigative subpoena to the MPDR by faxing to 406-841-2344 or emailing to email@example.com. All subpoenas, or their fax coversheets, must contain full contact information for the individual who will receive the report, including their work-related email address. All reports will be delivered digitally using a secure online file transfer service.
How to Read MPDR Law Enforcement Reports
Montana Board of Pharmacy: Click the “Drug Registry” tab
OTHER INFORMATION ON THIS PAGE
About the MPDR
About Prescription Drug Abuse
Additional Resources (online CME training for healthcare providers, screening tools, fact sheets, etc.)
ABOUT THE MPDR:
What is the MPDR? According to the Montana Patient Safety Act (§37-7-15, MCA), the purpose of the Montana Prescription Drug Registry (MPDR) is to improve patient safety. The MPDR is an online service that offers prescribers and dispensers the ability to search their patients’ medical history for controlled substance prescriptions. Medical providers can use the MPDR to enhance the quality of care they provide to their patients and, therefore, increase the level of patient safety when controlled substances are part of the treatment plan.
Why should I take time out of my busy schedule to use the MPDR? The MPDR is a powerful tool for health care providers (§37-7-15, MCA). By searching your patients’ prescription history, you will be able to review their prescription use patterns and confirm their medication history of controlled substances. In addition, emergency health care providers will be able to identify controlled substances that may have been ingested by an unresponsive patient. The information in the MPDR can empower you to make better treatment plans and, potentially, deter diversion of controlled substances for illegal use. In addition, by searching “My Prescribing History” you can examine all prescriptions that were dispensed under your DEA number, enabling you to identify any fraudulent use of your DEA registration.
Where does the MPDR's prescription information come from? All pharmacies holding an active Montana license, with the exception of Wholesale Drug Distributors, are required to report weekly to the MPDR. They must submit detailed information on all Schedule II – V drugs distributed to Montana residents during the previous week (§37-7-1503 MCA).
What data is stored in the MPDR? Pharmacies send us the detailed information they are required to collect for all controlled substance prescriptions they dispense. This includes information that identifies the patient and the prescriber; the pharmacy; the drug strength and dosage; refill information; and how the patient paid for their prescription.
Isn’t this information confidential? Yes, this information is protected and confidential information (§37-7-1505 MCA). Pursuant to §37-7-1506(6), MCA, the Montana Board of Pharmacy (Board) is required to maintain administrative rules regarding access to the MPDR that are consistent wit the Health Insurance Portability and Accountability Act of 1996 (HIPAA); Article II, section 10 of the Montana Constitution; and the privacy provisions of Title 50, chapter 16 of the MCA.
The MPDR enforces very strict limitations, as defined by law, about who can access the information and what they can do with it (§37-7-1506 MCA). The following Montana-licensed health care providers can access the online MPDR service: Physicians, Dentists, Naturopathic Physicians, Optometrists, Pharmacists, Physician Assistants, Podiatrists and APRNs with a Prescriptive Authority endorsement. Authorized representatives of Medicare, Medicaid, Tribal Health, Indian Health Services and Veterans Affairs may also access the online MPDR service. In addition, law enforcement officers may subpoena information related to an active investigation, and Licensing Board investigators may request information related to an open complaint against a licensee. There are criminal and administrative penalties for inappropriate use of the MPDR (§37-7-1513 MCA).
Who administers the MPDR? The Montana Board of Pharmacy is responsible for the operation and maintenance of the MPDR (§37-7-1502 MCA). For more information, visit www.Pharmacy.mt.gov and click on the Drug Registry tab.
What statutes and rules govern the MPDR? The Montana Patient Safety Act is Title 37, Chapter 7, Part 15 (§37-7-15, MCA). The Administrative Rules are Title 24, Chapter 174, Subchapter 17 (ARM 24.174.17).
How is the MPDR funded? The MPDR’s startup costs were funded through Grant No. 11-X01-91107 awarded by the Montana Board of Crime Control (MBCC) through the Office of Justice Programs, U.S. Department of Justice (DOJ). As of October 1, 2013, the MPDR was awarded a second grant from the same source, which will fund future enhancements to our online services. Additional funding for maintenance and monitoring will come from a controlled substance fee which will be paid by health care professionals who prescribe or dispense controlled substances (§37-7-1511 MCA). The MPDR began collecting these annual fees in 2013.
What is a controlled substance? By Federal and State statute, prescription drugs are divided into Schedules, or categories, based upon the type of drug being prescribed. The MPDR monitors Schedules II through V drugs, which are typically the most addictive or the most-often abused drugs on the market. Montana’s drug schedules can be found in §50-32, MCA .
More Information About the MPDR:
- Click the Drug Registry Tab on the Board of Pharmacy Website
- Billings Gazette: Overcoming the Grip of Pill Addiction (December, 2013)
- Billings Gazette: Death Rates Soar Among Women Using Prescription Drugs (December, 2013)
- KXLH Television News Story about the MPDR and Crime Control Board (October, 2013)
- Billings Gazette: Montana Must Stop Painkiller Abuse (June, 2013)
- Missoulian news series: Prescription For Addiction - discusses prescription drug abuse in Montana and identifies actions and resources that can help fight this epidemic, including the MPDR (May, 2013)
- KXLH Television news story about the MPDR (April, 2013)
The Center For Disease Control (CDC) considers prescription drug abuse to be an epidemic in this country. In some states, the per capita rate of death from prescription drug overdoses now exceeds the rates of death from auto accidents, gunshot wounds and non-prescription street drugs. Some patients become addicted after using these drugs for legitimate purposes, but many prescription drugs are also diverted from legitimate use into recreational use. This recreational use can start as early as elementary school or middle school; most children obtain these drugs from their family’s medicine chest or from a friend. Additionally, the CDC states that the rate of prescription drug overdose among women is rising at an alarming rate.
Is there a prescription drug problem in Montana?
Yes, and the rate of death due to prescription painkillers in Montana has been increasing. The February, 2013, issue of Montana Public Health has an excellent article giving the most current Montana statistics, as well as information on how health care providers can reduce prescription opiate misuse.
While Montana does not have the highest per capita death rate in the nation, we are fairly close to the top of the list. Various educational efforts are beginning to lower that number in Montana, but we still have a long way to go. Part of the problem is that addicts and drug diverters can be very creative in obtaining controlled substances. One typical method is to go “doctor shopping,” seeing multiple doctors for the same problem, and not telling any of the providers about other prescriptions they are receiving. These individuals will also use multiple pharmacies, especially when their local pharmacist recognizes them. Prior to the launch of the MPDR, health care providers in Montana were not able to identify these people unless the pharmacist or prescriber picked up the phone and called around to other doctors or pharmacies, a task few busy providers have time to perform.
More information about prescription drug abuse:
SAMSHA: Results from the 2012 National Survey on Drug Use and Health (September, 2013)
CDC: What States Can Do to Reverse the PDO Epidemic (July, 2013)
CDC: Vital Signs Fact Sheet – Prescription Painkiller Overdoses (July, 2013)
CDC: Morbidity & Mortality Weekly Report, Overdoses… Among Women (July, 2013)
Why the MPDR Matters to Your Patients
Montana Department of Justice (DOJ): Invisible Epidemic
Center For Disease Control (CDC) Grand Rounds: Prescription Drug Overdoses – a U.S. Epidemic. January, 2012.
National Institute on Drug Abuse (NIDA): Research That Can Inform Practice And Policy. Contains recent statistics and analyses, information on the biochemistry of opioid addiction, and more. June, 2012
Substance Abuse & Mental Health Services Administration (SAMHSA): Prescription Drug Abuse – Recognition, Intervention, and Prevention. June, 2012
U.S. Drug Enforcement Agency (DEA): Recognizing the Drug Abuser
DEA Office of Diversion Control Website
U.S. Congressional Research Service: Prescription Drug Monitoring Programs. July, 2012.
ADDITIONAL PROVIDER AND PATIENT RESOURCES
Safe Prescribing for Pain: 1.25 CME/CE Available
Managing Pain Patients Who Abuse Rx Drugs: 1.75 CME/CE Available
DoctorsSafeguard.com: this website offers numerous related podcasts.
Drug Screening Tool
Screening Resource Guide
Screening Quick Reference Guide
The Science of Addiction
Principles of Drug Addiction Treatment: A Research-Based Guide
The Medicine Abuse Project: Information and Resources for Families, Communities, Healthcare Providers and Law Enforcement
Opioid Overdose Prevention Toolkit (provided by SAMHSA):
- Information for Prescribers
- Information for Patients and Families
- Information for Communities
- Information for First Responders
- Information for Survivors
MPDR NEWSLETTER ARCHIVE
July 2013: Provider Newsletter